1 Kim J,Gosnell JE,Roman SA.Geographic influences in the global rise of thyroid cancer[J].Nat Rev Endocrinol,2020,16(1):17-29. 2 梁洁,王新华,王健.非远处转移性甲状腺乳头状癌131I疗效预测模型的分析[J].实用肿瘤学杂志,2022,36(3):220-225. 3 Lundgren CI,Hall P,Dickman PW,et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:A population-based,nested case-control study[J].Cancer,2006,106(3):524-531. 4 Moo TA,McGill J,Allendorf J,et al.Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma[J].World J Surg,2010,34(6):1187-1191. 5 Coscia F,Taler-Verˇciˇc A,Chang VT,et al.The structure of human thyroglobulin[J].Nature,2020,578(7796):627-630. 6 Trimboli P,Treglia G,Giovanella L.Preoperative measurement of serum thyroglobulin to predict malignancy in thyroid nodules:A systematic review[J].Horm Metab Res,2015,47(4):247-252. 7 Sakamoto K,Imanishi Y,Tomita T,et al.Usefulness and limitation of thyroglobulin measurement in fine needle aspirates(FNA-Tg)for diagnosis of neck lymph node metastasis from thyroid carcinoma[J].Nihon Jibiinkoka Gakkai Kaiho,2016,119(5):721-726. 8 Frasoldati A,Pesenti M,Gallo M,et al.Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma[J].Cancer,2003,97(1):90-96. 9 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. 10 Arianpoor A,Asadi M,Amini E,et al.Investigating the prevalence of risk factors of papillary thyroid carcinoma recurrence and disease-free survival after thyroidectomy and central neck dissection in iranian patients[J].Acta Chir Belg,2020,120(3):173-178. 11 Malterling RR,Andersson RE,Falkmer S,et al.Differentiated thyroid cancer in a swedish county--long-term results and quality of life[J].Acta Oncol,2010,49(4):454-459. 12 徐志勇,马晓良.甲状腺癌患者术后复发风险预测的列线图模型建立[J].实用肿瘤学杂志,2021,35(1):35-40. 13 Haugen BR,Alexander EK,Bible KC,et al.2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133. 14 李楠楠.甲状腺球蛋白联合血清CEA鉴别甲状腺良、恶性肿瘤中的应用价值[J].微量元素与健康研究,2022,39(6):16-17. 15 Mao J,Zhang Q,Zhang H,et al.Risk factors for lymph node metastasis in papillary thyroid carcinoma:A systematic review and meta-analysis[J].Front Endocrinol(Lausanne),2020,11:265. 16 Chang Q,Zhang J,Wang Y,et al.Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis[J].Front Endocrinol(Lausanne),2022,13:937049. 17 Pacini F,Fugazzola L,Lippi F,et al.Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses:A clue to the diagnosis of metastatic differentiated thyroid cancer[J].J Clin Endocrinol Metab,1992,74(6):1401-1404. 18 柴吉鑫,陈泳,齐艳涛,等.甲状腺球蛋白和抗体定量预测分化型甲状腺癌早期淋巴结转移的列线图模型[J].实用临床医药杂志,2021,25(21):7-11. 19 Wang Y,Liu Y,Wang X,et al.Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma[J].Onco Targets Ther,2017,10:4435-4441. 20 Dellal FD,Aydin C,Tam AA,et al.The value of serum thyroglobulin alteration after ultrasonography-guided fine-needle biopsy of suspicious cervical lymph nodes in the diagnosis of metastasis in patients with differentiated thyroid cancer[J].Int J Clin Pract,2021,75(7):e14218. 21 Peiris AN,Medlock D,Gavin M.Thyroglobulin for monitoring for thyroid cancer recurrence[J].JAMA,2019,321(12):1228. 22 Patell R,Mikhael A,Tabet M,et al.Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer:A retrospective cohort study[J].Endocrine,2018,61(3):506-510. 23 Kim H,Park SY,Choe JH,et al.Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer[J].Cancers(Basel),2020,12(3):1-10. 24 Kim H,Kim YN,Kim HI,et al.Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer[J].Sci Rep,2017,7(1):16955. 25 Feng Y,Min Y,Chen H,et al.Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma[J].J Endocrinol Invest,2021,44(10):2203-2211. 26 Feng JW,Hong LZ,Wang F,et al.A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary thyroid carcinoma[J].Front Endocrinol(Lausanne),2021,12:666315. 27 Zhou SC,Liu TT,Zhou J,et al.An ultrasound radiomics nomogram for preoperative prediction of central neck lymph node metastasis in papillary thyroid carcinoma[J].Front Oncol,2020,10:1591. 28 田军军,陶然,沈银峰,等.甲状腺癌患者血清甲状腺球蛋白以及抗甲状腺球蛋白抗体水平与肺转移、骨转移的相关性研究[J].海南医学院学报,2017,23(12):1679-1681. 29 刘安民,王永梅,李玥.分析甲状腺球蛋白(tg)与分化型甲状腺癌转移灶的相关性及tg的诊断意义[J].当代医学,2015,21(36):43-44. |